Skip to main content

Achieve Life Sciences Inc(ACHV-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low4.10
Day High4.25
Open:4.18
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Achieve Life Sciences Inc

Select a category then submit the form to load news
GlobeNewswire
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study
Tipranks
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Roivant Sciences (ROIV)
GlobeNewswire
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Opko Health (OPK), Achieve Life Sciences (ACHV)
GlobeNewswire
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
GlobeNewswire
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Tipranks
Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Tipranks
Achieve Life Sciences: Key Insights from Earnings Call
GlobeNewswire
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
GlobeNewswire
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
GlobeNewswire
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), BeOne Medicines (ONC)
GlobeNewswire
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
Tipranks
Achieve Life Sciences (ACHV) Gets a Buy from Raymond James
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Achieve Life Sciences (ACHV)
GlobeNewswire
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
Tipranks
Achieve Life Sciences Announces Leadership Change
GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
Tipranks
Lake Street Remains a Buy on Achieve Life Sciences (ACHV)
Tipranks
Achieve Life Sciences (ACHV) Receives a Buy from JonesTrading
GlobeNewswire
Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD
GlobeNewswire
Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer
Tipranks
Achieve Life Sciences Announces Leadership Change
GlobeNewswire
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
Tipranks
Lake Street Sticks to Their Buy Rating for Achieve Life Sciences (ACHV)
GlobeNewswire
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
GlobeNewswire
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Tipranks
Achieve Life Sciences’ Earnings Call Highlights Progress and Challenges
Tipranks
Achieve Life Sciences Advances Cytisinicline Development
Tipranks
JonesTrading Remains a Buy on Achieve Life Sciences (ACHV)
Motley Fool
Achieve (ACHV) Q2 Net Loss Hits $12.7M
GlobeNewswire
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Profile

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.